Ted Buchan & Co. has filed its Form 13F-HR, disclosing the firm's equity securities holdings as of the close of business on September 30, 2026. The filing lists a total of 94 securities held by the firm, with the majority of positions held in a sole voting capacity.
The largest holding reported in the filing is a position in Novo-Nordisk A S ADR, where the firm holds 4,213,852 shares. Other significant positions include shares of Pfizer Inc. (542,950 shares), Eli Lilly & Co. (3,999 shares), and Ambev SA Sponsored ADR (321,188 shares). The filing also details positions in major technology companies such as Microsoft (6,306 shares), Apple (2,286 shares), Alphabet Class C (14,527 shares), and Amazon (22,008 shares).
In addition to individual equities, the portfolio includes various exchange-traded funds (ETFs). The firm holds substantial stakes in ETFIS Ser Tr I Virtus Reaves UTR (136,387 shares), Invesco Exchange Traded FD T S&P500 Eql Wgt (47,56 shares), and Invesco Exchange Traded FD T RAFI US 1000 ETF (314,378 shares). Other ETFs listed in the filing include the iShares MSCI Brazil ETF (150,676 shares), the iShares Core S&P 500 ETF (20,583 shares), and the Vanguard Total Stock Market ETF (5,116 shares).
The filing was signed by Eric Schmid, Chief Compliance Officer, on October 23, 2026.
